- Home
- ATXS vs SLQT Comparison
ATXS vs SLQT Comparison
Compare ATXS & SLQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- SLQT
- Stock Information
- Founded
- ATXS 2008
- SLQT 1999
- Country
- ATXS United States
- SLQT United States
- Employees
- ATXS N/A
- SLQT N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- SLQT Specialty Insurers
- Sector
- ATXS Health Care
- SLQT Finance
- Exchange
- ATXS Nasdaq
- SLQT Nasdaq
- Market Cap
- ATXS 401.2M
- SLQT 343.7M
- IPO Year
- ATXS 2015
- SLQT 2020
- Fundamental
- Price
- ATXS $7.52
- SLQT $2.07
- Analyst Decision
- ATXS Buy
- SLQT Hold
- Analyst Count
- ATXS 6
- SLQT 2
- Target Price
- ATXS $32.00
- SLQT $4.38
- AVG Volume (30 Days)
- ATXS 298.2K
- SLQT 2.8M
- Earning Date
- ATXS 08-12-2025
- SLQT 11-03-2025
- Dividend Yield
- ATXS N/A
- SLQT N/A
- EPS Growth
- ATXS N/A
- SLQT N/A
- EPS
- ATXS N/A
- SLQT 0.01
- Revenue
- ATXS N/A
- SLQT $1,526,594,000.00
- Revenue This Year
- ATXS N/A
- SLQT $13.85
- Revenue Next Year
- ATXS N/A
- SLQT $13.64
- P/E Ratio
- ATXS N/A
- SLQT $155.28
- Revenue Growth
- ATXS N/A
- SLQT 15.50
- 52 Week Low
- ATXS $3.56
- SLQT $1.62
- 52 Week High
- ATXS $12.92
- SLQT $6.86
- Technical
- Relative Strength Index (RSI)
- ATXS 64.14
- SLQT 45.92
- Support Level
- ATXS $6.50
- SLQT $2.01
- Resistance Level
- ATXS $6.82
- SLQT $2.77
- Average True Range (ATR)
- ATXS 0.44
- SLQT 0.19
- MACD
- ATXS 0.07
- SLQT -0.02
- Stochastic Oscillator
- ATXS 96.62
- SLQT 28.06
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.